75 related articles for article (PubMed ID: 16491056)
1. [Pathophysiological and therapeutic implications of nitric oxide in hepatology].
Battista S; Bar F; Pollet C; Mengozzi G; Molino G
Minerva Gastroenterol Dietol; 2002 Dec; 48(4):309-18. PubMed ID: 16491056
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and liver disease.
Abrams GA; Trauner M; Nathanson MH
Gastroenterologist; 1995 Sep; 3(3):220-33. PubMed ID: 8535773
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of portal hypertension.
Cichoz-Lach H; Celiński K; Słomka M; Kasztelan-Szczerbińska B
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():231-8. PubMed ID: 18812641
[TBL] [Abstract][Full Text] [Related]
5. Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion.
Wang XL; Liu HR; Tao L; Liang F; Yan L; Zhao RR; Lopez BL; Christopher TA; Ma XL
Apoptosis; 2007 Jul; 12(7):1209-17. PubMed ID: 17333318
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
Gatta A; Bolognesi M; Merkel C
Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
[TBL] [Abstract][Full Text] [Related]
7. Conservation of whole body nitric oxide metabolism in human alcoholic liver disease: implications for nitric oxide production.
Demoncheaux EA; Elphick DA; Dürner MB; Higgins GE; Crowther D; Williams EJ; Higenbottam TW; Gleeson D
Scand J Gastroenterol; 2006 Jul; 41(7):820-5. PubMed ID: 16785195
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological preconditioning using intraportal infusion of L-arginine protects against hepatic ischemia reperfusion injury.
Giovanardi RO; Rhoden EL; Cerski CT; Salvador M; Kalil AN
J Surg Res; 2009 Aug; 155(2):244-53. PubMed ID: 19540520
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
Gong J; Lao XJ; Zhang SJ; Chen S
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
[TBL] [Abstract][Full Text] [Related]
10. Effect of adrenomedullin on hepatic damage in hepatic ischaemia/reperfusion injury in rats.
Kerem M; Bedirli A; Pasaoglu H; Ofluoğlu E; Yilmazer D; Salman B; Yilmaz TU
Liver Int; 2008 Aug; 28(7):972-81. PubMed ID: 18435717
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
Pannu R; Singh I
Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
[TBL] [Abstract][Full Text] [Related]
13. Liver tissue inducible nitric oxide synthase (iNOS) expression and lipid peroxidation in experimental hepatic ischemia reperfusion injury stimulated with lipopolysaccharide: the role of aminoguanidine.
Yaylak F; Canbaz H; Caglikulekci M; Dirlik M; Tamer L; Ogetman Z; Polat Y; Kanik A; Aydin S
J Surg Res; 2008 Aug; 148(2):214-23. PubMed ID: 18222473
[TBL] [Abstract][Full Text] [Related]
14. The future treatment of portal hypertension.
Reichen J; Lebrec D
Best Pract Res Clin Gastroenterol; 2007; 21(1):191-202. PubMed ID: 17223505
[TBL] [Abstract][Full Text] [Related]
15. Oxidative and nitrosative stress in pediatric pulmonary hypertension: roles of endothelin-1 and nitric oxide.
Black SM; Fineman JR
Vascul Pharmacol; 2006 Nov; 45(5):308-16. PubMed ID: 17049313
[TBL] [Abstract][Full Text] [Related]
16. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule.
Iwakiri Y; Groszmann RJ
Hepatology; 2006 Feb; 43(2 Suppl 1):S121-31. PubMed ID: 16447289
[TBL] [Abstract][Full Text] [Related]
17. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury.
Tiegs G
Z Gastroenterol; 2007 Jan; 45(1):63-70. PubMed ID: 17236122
[TBL] [Abstract][Full Text] [Related]
18. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
20. Effects of sphingosylphosphorylcholine against cholestatic oxidative stress and liver damage in the common bile duct ligated rats.
Aksu B; Umit H; Kanter M; Guzel A; Inan M; Civelek S; Aktas C; Uzun H
J Pediatr Surg; 2009 Apr; 44(4):702-10. PubMed ID: 19361629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
